Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDB-2914 in Post-Menopausal Women
NCT00009659Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ulipristal in postmenopause (3 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Endometrial thickness at 6 weeks. Started Jan 2001; status: completed.
02
Drugs
ulipristal
03
Conditions
postmenopause
Beyond the preview
Go deeper on NCT00009659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009659.